MANGLAVITI, SARA

MANGLAVITI, SARA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 8 di 8 (tempo di esecuzione: 0.026 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers 1-gen-2020 Fabbroni, ChiaraManglaviti, SaraFumagalli, ElenaCasali, Paolo GSanfilippo, Roberta + Article (author) -
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer 1-gen-2022 Galli, GiuliaCorsetto, Paola AntoniaBrambilla, MartaOcchipinti, MarioManglaviti, SaraVingiani, AndreaRizzo, Angela Mariade Braud, Filippo + Article (author) -
Comparison of outcomes of central venous catheters in patients with solid and hematologic neoplasms: an Italian real-world analysis 1-feb-2021 Manglaviti S.de Braud F. + Article (author) -
Evaluation of drug-drug interactions in EGFR-mutated non-small-cell lung cancer patients during treatment with tyrosine-kinase inhibitors 18-mag-2021 Manglaviti S.Beninato T.Zattarin E.De Braud F. + Article (author) -
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology 1-gen-2022 Manglaviti S.Beninato T.Zattarin E.Lobefaro R.Bottiglieri A.Apollonio G.de Braud F. G. M. + Article (author) -
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy 1-gen-2022 Boeri M.Lo Russo G.Manglaviti S.Beninato T.Bottiglieri A.Zattarin E.Galli E. G.de Braud F. G. M. + Article (author) -
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program 1-mag-2021 Bottiglieri A.Lobefaro R.Nichetti F.Manglaviti S.de Braud F. + Article (author) -
Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients : A Multi-institutional Analysis 1-set-2020 Pagani FPrisciandaro MManglaviti SPietrantonio F + Article (author) -